Soma Pharmacy Blognews

No Health Insurance, Higher Death Risk
In a new study, researchers estimate that 45,000 deaths per year in the U.S. are associated with not having health insurance.

Kids Have Strokes More Often Than Thought
Strokes in children are rare — about 2.4 per 100,000 kids per year in the U.S. — but that’s two to four times more often than previous estimates, new data show.

37% of U.S. Teens Got HPV Vaccine
37% of U.S. teen girls got at least 1 shot of Gardasil, a vaccine against sexually transmitted cancer- and wart-causing HPV viruses. But only 18% have finished the 3-shot series.

Quidel’s QuickVue Influenza A+B test receives special 510(k) clearance for H1N1 reactivity update
Quidel Corporation (NASDAQ: QDEL), a global leader in point-of-care (POC) rapid diagnostic tests, received Special 510(k) clearance for an update to the Company’s QuickVue® Influenza A+B test package insert to include reactivity with culture isolates of the 2009 H1N1 Influenza A virus.

A not-for-profit mission from Wellcome Trust and Merck to develop affordable vaccines for low-income countries
The Wellcome Trust and Merck & Co., Inc. today announced the creation of the MSD Wellcome Trust Hilleman Laboratories (www.hillemanlaboratories.in), the first of its kind research and development joint venture with a not-for-profit mission to focus on developing affordable vaccines to [...]

Nimotuzumab drug approved for Mexican distribution
YM BioSciences Inc. (NYSE Amex:YMI, TSX:YM, AIM:YMBA), a life sciences product development company that identifies and advances a diverse portfolio of promising cancer-related products at various stages of development, today reported that nimotuzumab has been approved for marketing in Mexico.

FDA: Manufacturers to include warning of promethazine hydrochloride injection on labels
The U.S. Food and Drug Administration is telling manufacturers of the drug promethazine to include a boxed warning regarding the injectable form of the drug.

LAB Research signs exclusive agreement to extend Korean market
LAB Research Inc. (“LAB”, “LAB Research” or the “Company”), (TSX: LRI), a Canadian-based global non-clinical contract research organization, today announced that it has extended its Korean market coverage through a new exclusive agency agreement with Safe Chemicals Co., LTD., a South Korea based consulting company (“Safe Chemicals”).

Report on Polyphosphazenes for Biomedical Applications
Research and Markets (http://www.researchandmarkets.com/research/493c2f/polyphosphazenes_f) has announced the addition of John Wiley and Sons Ltd’s new report “Polyphosphazenes for Biomedical Applications” to their offering.

DDI Predict 2009 edition assessing the risk of potential drug-drug interactions released
Aureus Pharma, a leading provider of knowledge management solutions to accelerate discovery in the life sciences industry, announces today the release of the 2009 Edition of DDI Predict. This innovative software application adds a number of enhancements to assess the risk of potential drug-drug [...]